This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.

Magdalena Tary-Lehmann M.D., PhD., Adj. Prof.

CSO, Vice-President, and Cofounder of CTL

Personal Statement
Throughout my career I have pursued a better understanding of the cellular immune system and its functions through the evaluation of immune responses. This effort led to the development of diverse ImmunoSpot® assay platforms, as well as how to handle and freeze the cells needed for testing. As a cofounding Scientist of Cellular Technology Limited (CTL) and its CSO I pride myself in translating these scientific achievements into the clinical arena. As the CEO of CTL Contract Laboratory, I oversee the development, standardization, and performance of immunological assays in a GCP, GLP- and CLIA compliant setting for our clients in different fields including pharmaceutical and biotechnology companies.

Education and Training
  • M.D., University of Tübingen, Germany
  • Ph.D., University of Tübingen, Germany
  • Postdoc, University of California, Los Angeles, Division of Clinical Immunology and Allergy, with Andrew Saxon
  • Instructor, Assistant, Associate Professor with Tenure at Case Western, Cleveland
  • CSO of CTL
  • CEO of CTL Contract Laboratory
Publications (ResearchGate: h-index 36, 77 publications, 4750 citations):
  • Tary-Lehmann, M., Rolink, A.G., Lehmann, P.V., Nagy, Z.A., and Hurtenbach, U. Induction of graft versus host-associated immunodeficiency by CD4+ T-cell clones. J. Immunol. 1990. 145:2092-2098.
  • Saxon, A., Macy, E., Denis, K., Tary-Lehmann, M., Witte, O., and Braun, J. Limited B-cell repertoire in severe combined immunodeficient mice engrafted with peripheral blood mononuclear cells derived from immunodeficient or normal humans. J. Clin. Invest. 1991. 87:658-665.
  • Lehmann, P.V., Drexler, K., Tary-Lehmann, M., Falcioni, F., Hurtenbach, U., and Nagy, Z.A. Graft-versus-host resistance induced by class II major histocompatibility complex-specific T-cell clones. J. Exp. Med. 1991. 173:333-341.
  • Tary-Lehmann, M., and Saxon, A. Human mature T cells that are anergic in vivo prevail in SCID mice reconstituted with human peripheral blood. J. Exp. Med. 1992. 175: 503-516.
  • Uittenbogaart, C.H., Anismann, D.J., Tary-Lehmann, M., Vollger, L.W., Breit, T., Van Dongen, J. and Saxon, A. The SCID mouse environment causes immunophenotypic changes in human immature T-cell lines. Int. J. Cancer 1994. 56: 546-551
  • Tary-Lehmann, M., Lehmann, P.V., Schols, D., Roncarolo, M.G. and Saxon A. Anti-SCID mouse reactivity shapes the human CD4+ T cell repertoire in hu-PBL-SCID chimeras. J. Exp. Med. 1994. 180: 1817-1827
  • Tary-Lehmann M., Saxon, A. and Lehmann, P.V. The human immune system in hu-PBL-SCID mice. Immunol. Today 1995. 16: 529-533
  • Gross,D.M., Forsthuber T., Tary-Lehmann M., Etling C., Ito K., Nagy Z., Field J. A., Steere A.C. and Huber B.T. Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritis. Science 1998. 281:703-706
  • Tary-Lehmann, M., Hricik, D., Potter, N.S., Robinson, and H., Heeger, P.S. High Interferon gamma to IL-5 ratio as a surrogate marker for renal allograft rejection. Transplantation 1998. 66:219-224
  • Schwander S. K., Torres M., Sada E., Carranza C., Ramos E., Tary-Lehmann M., Wallis R. S., SierraJ and Rich E. A. Enhanced responses to Mycobacterium tuberculosis antigens by alveolar lymphocytes during active pulmonary tuberculosis. J. Infect. Dis. 1998; 178:1434-1445
  • Targoni O.S., Tary-Lehmann M. and Lehmann P. Prevention of murine EAE by oral hydrolytic enzyme treatment. Journal of Autoimmunity 1999 12:191-198
  • Yip H.C., Karulin A.Y., Tary-Lehmann M., Hesse M.D., Radeke H., Heeger P.S., Trezza R.P., Heinzel F.P., Forsthuber T., Lehmann P.V. Adjuvant-guided type-1 and type-2 immunity: infectious/noninfectious dichotomy defines the class of response. J. Immunol. 1999, 162:3942-3949
  • Heeger P. S., Greenspan N.S., Kuhlenschmidt S., Dejelo C., Hricik D.E., Schulak J. A. and Tary-Lehmann M. Pretransplant frequency of donor specific, IFN-γ producing lymphocytes is a manifestation of immunologic memory and correlates with the risk of posttransplant rejection episodes. J. Immunol. 1999, 163:2267-2275
  • Karulin A.Y., Hesse M.D., Tary-Lehmann M. and Lehmann P.V. Single-cytokine-producing CD4 memory cells predominate in type 1 and type 2 immunity. J. Immunol. 2000, 164:1862-1872
  • Helms T., Asaad R.J., Trezza R.P., Lehmann P.V. and Tary-Lehmann M. Direct visualization of cytokine producing recall antigen specific memory T cells in HIV patients and healthy individuals. J. Immunol. 2000, 164: 3723-3732
  • Rininsland F.H., Helms T., Asaad R.J., Boehm B.O. and Tary-Lehmann M. Granzyme B ELISPOT assay for ex vivo measurement of T cell immunity. J. Immunol. Methods 2000, 240: 143-155
  • Schwander S.K., Torres M., Carranza C.C., Escobedo D., Tary-Lehmann M., Anderson P., Toossi Z., Ellner J.J. and Sada E. Pulmonary mononuclear cell responses to antigens of Mycobacterium tubercolosis in healthy houshold contacts of patients with active tuberculosis and healthy controls from the community J. Immunol. 2000, 165:1479-1485
  • Pelfry C.M., Rudick R.A., Cotleur A.C., Lee Jar-Chi, Tary-Lehmann M. and Lehmann P. V. Quantification of self-recognition in multiple sclerosis by single-cell analysis of cytokine production. J. Immunol. 2000, 165:1641-1651
  • Anderson, M. and Tary-Lehmann M. Staphylococcal enterotoxin B-induced lethal shock in mice is T cell dependent, but disease susceptibility is defined by the non-T-cell compartment. Clin. Immunol. 2001, 98: 85-94
  • Baron E.D., Heeger P.S., Hricik D.E., Shulak J.A., Tary-Lehmann M. and Stevens S.R. Immunomodulatory effect of extacorporeal photopheresis after successful treatment of resistant renal allograft rejection. Photodermatol. Photo. 2001, 17: 79-82
  • Hesse M.D., Karulin A.Y., Boehm B.B., Lehmann P.V., Tary-Lehmann M. T cell avidity is a function of T cell's activation state. J. Immunol. 2001, 167:1353-1361
  • Gottwein J.M., Blanchard T.G., Targoni O.A., Eisenberg J.G.C., Zagorski B. M.,Redline R.V., Nedrud J.G., Tary-Lehmann M., Lehmann P.V. and Czinn S.J. Protective anti-Helicobacter immunity is induced with aluminium hydroxide or complete freud’s adjuvant by systemic immunization. J. Infect. Dis. 2001:184:308-314
  • Stern B.V., Boehm B.B. and Tary-Lehmann M. Vaccination with tumor peptide in CpG adjuvant protects via IFN-γ-dependent CD4 cell immunity. J. Immunol. 2002,168: 6099-6105
  • Aung H., Sherman J., Tary-Lehmann M. and Toossi Z. Production of transforming growth factor-beta 1 (TGF-1) expression in human monocytes infected with Mycrobacterium Avium at a single cell level by ELISPOT assay. J. Immunol. Methods 2002, 259:25-32
  • Radeke H.H., Tschernig T., Karulin A., Schumm G., Emancipator S. N., Resch K., Tary-Lehmann M. CD4+ T cells recognizing specific antigen deposited in glomeruli cause glomerulonephritis-like kidney injury. Clinical Immunology. 2002, 104: 161-173
  • Gebauer B.S., Hricik D.E., Atallah A., Bryan K., Riley J., Tary-Lehmann M., Greenspan N.S., Boehm B.O., Hering B.J. and Heeger P.S. Evolution of the Enzyme-Linked Immunosorbent Spot Assay for Post-Transplant Alloreactivity as a Potentially Useful Immunme Monitoring Tool Am. J. Transplant. 2002; 2(9) 857
  • Li R., Liu T., Yoshihiro F., Tary-Lehmann M., Orenovich M., Kuekrek H., Kang S.H. Pan T., Wong B.S., Medof E.M., and Sy M. On the same cell type GPI anchord normal cellular prion and DAF protein exhibit different biological properties. BBRC 2003, 303: 446-451
  • D.E. Hricik, V. Rodriguez, R.N. J. Riley, K. Bryan, M. Tary-Lehmann, N. Greenspan,C. Dejelo J.A. Schulak, and P.S. Heeger. Enzyme linked immunosorbent spot (ELISPOT) assay for interferon-gamma independently predicts renal function in kidney transplant recipients. Am J Transplant 2003, 3(7):878-84
  • Kreher C.R., Dittrich M.T., Guerkov R., Boehm. B.O. and Tary-Lehmann M. CD4+ and CD8+ cells in cryopreserved human PBMC maintain full functionality in cytokine ELISPOT assays. J. Immunol. Methods, 2003, 278:79-93
  • Guerkov R.E.M., Targoni O.S., Kreher C.R., Boehm B.O., Herrera M.T., Tary-Lehmann M., Lehmann P.V. and Schwander S.K. Detection of low frequency antigen-specific IL-10-producing CD4+ T cells via ELISPOT in PBMC: cognate vs. nonspecific production of the cytokine. J. Immunol. Methods 2003, 279:111-121
  • Lonsdorf A.S., Kuekrek H., Stern B.V., Boehm B.O., Lehmann P.V. and Tary-Lehmann M. Intratumor CpG-Oligodeoxynucleotide Injection Induces Protective Antitumor T Cell Immunity. J. Immunol. 2003, 171: 3941-3946.
  • S. Kadereit, G. R. Junge, T. Kleen, M. M. Kozik, K. Daum-Woods, P. Fu, R. M. Sramkoski, J. W. Jacobberger, M. Tary-Lehmann and M. J. Laughlin; Deficient IFN-γ expression in umbilical cord blood (UCB) T cells can be rescued by IFN-γ-mediated increase in NFAT1 expression J. Clin. Immunol. 2003, 23: 485-497
  • Kleen T.O., Assad R., Landry S., Boehm B.O. and Tary-Lehmann M. Tc1 effector cell diversity in HIV infection: dissociated expression of IFN-γ and of granzyme B by peptide-specific CD8 cells. AIDS 2004, 18(3): 20 383-392
  • Ott P.A., Berner B.R., Herzog B.A., Guerkov R., Yonkers N.L., Boehm B.O., Durinovic-Bello I., Tary-Lehmann M., Lehmann P.V. and Anthony D.D. CD28 costimulation enhances the sensitivity of the ELISPOT assay for detection of antigen-specific memory effector CD4+ and CD8+ cell populations in human diseases. J. Immunol. Methods 2004, 285:223-235
  • Ott P.A., Dittrich M. T., Herzog B.A., Guerkov R., Gottlieb P.A., Putnam A.L., Durinovic-Bello I., Boehm B.O., Tary-Lehmann M., and Lehmann P.V. T cells recognize multiple GAD65 and Proinsulin epitopes in human type 1 diabetes, suggesting determinant spreading. J. Clin. Immunol. 2004, 24: 327-339
  • Darabi K., Karulin A. Y., Boehm B. O., Hofstetter H. H., Fabry Z., LaManna J. C., Chavez J. C., Tary-Lehmann M., and Lehmann P.V. The Third Signal in T Cell-Mediated Autoimmune Disease? J. Immunol. 2004 173: 92-99.
  • Bartholomae W.C., Rininsland F.H., Eisenberg J.C. Boehm O. B., P. V. Lehmann and Tary-Lehmann M. T cell immunity induced by live, necrotic and apoptotic tumor cells. J. Immunol. 2004, 173: 1012-1022.
  • Herzog B.A., Ott P.A., Dittrich M.T., Quast S., Karulin A.Y., Kalbacher H., Karges W., Tary-Lehmann M., Lehmann P.V., Boehm B.O., Durinovic-Bello I. Increased in vivo frequency of IA-2 peptide-reactive IFN gamma(+)/IL-4(-) T cells in type 1 diabetic subjects. J. Autoimmun. 2004, 23(1):45-54.
  • Cox JH, Ferrari G, Kalams SA, Lopaczynski W, Oden N, D'Souza MP and the ELISPOT Collaborative Study Group. Results of an ELISPOT Proficiency Panel Conducted in 11 Laboratories Participating in International Human Immunodeficiency Virus Type 1 Vaccine trials. AIDS Research & Human Retroviruses. 2005 21: 68-81.
  • Ott PA, Herzog BA, Quast S, Hofstetter HH, Boehm BO, Tary-Lehmann M, Durinovic-Bello I, Berner BR, Lehmann PV. Islet cell antigen-specific T cells show different expansion rates and Th1/Th2 differentiation in Type 1 diabetics and healthy controls. Clinical Immunology, 2005, 115(1):102-14
  • H. H. Hofstetter, O. S. Targoni, A. Y. Karulin, T. G. Forsthuber, M. Tary-Lehmann and P. V. Lehmann. Does the frequency and avidity spectrum of the neuroantigen-specific T cells in the blood mirror the autoimmune process in the CNS of mice undergoing EAE? J. Immunol., 2005, 174: 4598-4605
  • Berner R. B., Tary-Lehmann M., Yonkers N.L., Askari A.D., Lehmann P. V., Anthony D. D. Phenotypic and functional analysis of EBV-specific memory CD8 cells in SLE Cellular Immunology 2005, 235: 1, pp: 29-38
  • Ott, P. A.; Anderson M. R.; Tary-Lehmann, M.; Lehmann P. V. CD4+CD25+ regulatory T cells control the progression from periinsulitis to destructive insulitis in murine autoimmune diabetes. Cell. Immunol. 235:1-11, 2005
  • H. Kuekrek, T. Schlingmann, B. O. Boehm, H. Valdez, R.B. Pollard, R. Mitsuyasu, M. M. Lederman, P. V. Lehmann and M. Tary-Lehmann. Differential effect of IL-2 treatment on primary and secondary immunizations in HIV infected individuals. AIDS 2005, Nov 18;19(17):1967-1974
  • Kleen T. O., Kadereit S., Fanning L. R., Jaroscak J., Fu P., Meyerson H.J., Kulchycki L., Slivka L. F., Kozik M., Huang J., Tary-Lehmann M., and Laughlin M.J.¶ Recipient-specific tolerance after HLA-mismatched umbilical cord blood stem cell transplantation Transplantation 2005 (¶Two last authors contributed equally) 80(9):1316-1322
  • Hofstetter H.H, A. Y. Karulin, T. G. Forsthuber, P. A. Ott, M. Tary-Lehmann and P. V. Lehmann. The cytokine signature of MOG-specific CD4 cells in the EAE of C57.Bl/6 mice. J. Neuroimmunology, 2005 170:105-114
  • Quast, S., W. Zhang, C. Shive, D. Kovalovski, P. Ott, B. Herzog, B. O. Boehm, M. Tary-Lehmann, A. Karulin and P. V. Lehmann. IL-2 Absorption Affects IFN-ү and IL-5, but not IL-4 Producing Memory T Cells in Double Color Cytokine ELISPOT Assays Cellular Immunology 2005, 237(1):28-36
  • Kuerten S., Lichtenegger F. S., Faas S., Angelov D. N., Tary-Lehmann M. and Lehmann P.V. MBP-PLP fusion protein-induced EAE in C57BL/6 mice., J Neuroimmunol. 2006 Aug;177(1-2):99-111. Epub 2006 Jun 15
  • Hofstetter HH, Toyka KV, Tary-Lehmann M, Lehmann PV. Kinetics and organ distribution of IL-17-producing CD4 cells in proteolipid protein 139-151 peptide-induced experimental autoimmune encephalomyelitis of SJL mice. J. Immunol. 2007 Feb 1;178(3):1372-8.
  • Lichtenegger FS, Kuerten S, Faas S, Boehm BO, Tary-Lehmann M, Lehmann PV. Dissociation of experimental allergic encephalomyelitis protective effect and allergic side reactions in tolerization with neuroantigen. J. Immunol. 2007 Apr 15;178(8):4749-56.
  • PA Ott, M Tary-Lehmann and PV Lehmann. The secretory IFN-γ response of single CD4 memory cells after activation on different antigen presenting cell types. Clin. Immunol. 2007 Sep;124(3):267-76.
  • Kuerten S, Kostova-Bales DA, Frenzel LP, Tigno JT, Tary-Lehmann M, Angelov DN, Lehmann PV. MP4- and MOG:35-55-induced EAE in C57BL/6 mice differentially targets brain, spinal cord and cerebellum. J. Neuroimmunol. 2007 Sep; 189 (1-2):31-40. Epub 2007 Jul 25.
  • Nowacki TM, Kuerten S, Zhang W, Shive CL, Kreher CR, Boehm BO, Lehmann PV, Tary-Lehmann M. Granzyme B production distinguishes recently activated CD8(+) memory cells from resting memory cells. Cell. Immunol. 2007 May; 247 (1):36-48. Epub 2007 Sep 7.
  • S. Kuerten, T. M. Nowacki, T. O. Kleen, R. J. Asaad, P. V. Lehmann, M. Tary-Lehmann. Dissociated Production of Perforin, Granzyme B, and IFN-γ by HIV-Specific CD8+ Cells in HIV Infection. AIDS Research and Human Retroviruses. 2008, 24(1): 62-71.
  • D. Mirano-Bascos, M. Tary-Lehmann and S. J. Landry. Antigen structure influences helper T-cell epitope dominance in the human immune response to HIV envelope glycoprotein gp120. Eur J Immunol. 2008 May;38(5):1231-7.
  • Fanning L. R., Hegerfeldt Y., Tary-Lehmann M., Lesniewski M., Maciejewski J., Weitzel R. P., Kozik M., Finney M., Lazarus H.M., Paul P., Ratajczak M.Z., Meyerson H.J., Laughlin M.J. Allogeneic transplantation of multiple umbilical cord blood units in adults: role of pretransplant-mixed lymphocyte reaction to predict host-vs-graft rejection. Leukemia. 2008 Sep;22(9):1786-90.
  • Kuerten S, Javeri S, Tary-Lehmann M, Lehmann PV, Angelov DN. Fundamental differences in the dynamics of CNS lesion development and composition in MP4- and MOG peptide 35-55-induced experimental autoimmune encephalomyelitis. Clin Immunol. 2008 Aug 21.
  • Kuerten S, Schlingmann TR, Rajasalu T, Angelov DN, Lehmann PV, Tary-Lehmann M. Lack of disease specificity limits the usefulness of in vitro costimulation in HIV- and HCV-infected patients. Clin Dev Immunol. 2008; 2008:590941.
  • M. Tary-Lehmann, C. D. Hamm and P. V. Lehmann. Book " Validation of Cell-based Assays in the GLP Setting", edited by Uma Prabhakar and Marian Kelley. Chapter: Validating reference samples for comparison in a regulated ELISPOT assay. Published on 07 2008 ISBN: 97804700287662008.
  • Kuerten S., Asaad R. J., Schoenberger, S. P. Lehmann P. V., and Tary-Lehmann M. The TRAIL of helpless CD8+ T cells in HIV infection AIDS Res Hum Retroviruses. 2008 Sep;24(9):1175-83.
  • Loewenbrueck KF, Tigno-Aranjuez JT, Boehm BO, Lehmann PV, Tary-Lehmann M. Th1 responses to beta-amyloid in young humans convert to regulatory IL-10 responses in Down syndrome and Alzheimer's disease. Neurobiol Aging. 2010 Oct; 31(10):1732-42. Epub 2008 Dec 5.
  • Yonkers NL, Milkovich KA, Rodriguez B, Post AB, Asaad R, Heinzel FP, Valdez H, Tary-Lehmann M, Anthony DD. Accessory cell dependent NK cell mediated PBMC IFN-gamma production is defective in HIV infection. Clin Immunol. 2009 May;131(2):288-97.
  • Tigno-Aranjuez JT, Lehmann PV, Tary-Lehmann M. Dissociated induction of cytotoxicity and DTH by CFA and CpG. J Immunother. 2009 May;32(4):389-98.
  • Schlingmann TR, Shive CL, Targoni OS, Tary-Lehmann M, Lehmann PV. Increased per cell IFN-gamma productivity indicates recent in vivo activation of T cells. Cell Immunol. 2009;258(2):131-7. Epub 2009 May 8. (*Two last authors contributed equally).
  • Schlingmann TR, Rininsland FH, Bartholomae WC, Kuekrek H, Lehmann PV, Tary-Lehmann M. Vaccination with tumor cells pulsed with foreign peptide induces immunity to the tumor itself. Clin Immunol. 2009 Oct;133(1):45-51.
  • Conry SJ, Milkovich KA, Yonkers NL, Rodriguez B, Bernstein HB, Asaad R, Heinzel FP, Tary-Lehmann M, Lederman MM, Anthony DD. Impaired plasmacytoid dendritic cell (PDC)-NK cell activity in viremic human immunodeficiency virus infection attributable to impairments in both PDC and NK cell function. J Virol. 2009 Nov;83(21):11175-87.
  • Tigno-Aranjuez JT, Jaini R, Tuohy VK, Lehmann PV, Tary-Lehmann M. Encephalitogenicity of complete freund's adjuvant relative to CpG is linked to induction of Th17 cells. J Immunol. 2009 Nov 1;183(9):5654-61.
  • Kuerten S, Rodi M, Javeri S, Gruppe TL, Tary-Lehmann M, Lehmann PV, Addicks K. Delineating the impact of neuroantigen vs genetic diversity on MP4-induced EAE of C57BL/6 and B6.129 mice. APMIS. 2009; 117(12):923-35.
  • Kuerten S, Rottlaender A, Rodi M, Velasco VB Jr, Schroeter M, Kaiser C, Addicks K, Tary-Lehmann M, Lehmann PV. The clinical course of EAE is reflected by the dynamics of the neuroantigen-specific T cell compartment in the blood. Clin Immunol. 2010 Dec;137(3):422-32. Epub 2010 Oct 8. (¶Two last authors contributed equally)
  • Javeri S, Rodi M, Tary-Lehmann M, Lehmann PV, Addicks K, Kuerten S. Involvement of brain-derived neurotrophic factor (BDNF) in MP4-induced autoimmune encephalomyelitis. Clin Immunol. 2010 Nov;137(2):181-9. Epub 2010 Aug 24.
  • Kuerten S, Pauly R, Rottlaender A, Rodi M, Gruppe TL, Addicks K, Tary-Lehmann M, Lehmann PV. Myelin-reactive antibodies mediate the pathology of MBP-PLP fusion protein MP4-induced EAE. Clin Immunol. 2011 Jul;140(1):54-62. Epub 2011 Apr 13.
  • Moldovan I R and Tary-Lehmann M. Meeting Report: Improving immunogenicity, efficacy and safety of vaccines through innovation in clinical assay development and trial design - The Phacilitate Vaccine Forum, Washington D.C. 2011. Human Vaccines, June 2011, volume 7, issue 6, pp. 610-612.
  • Osorio J E, Brewoo J N, Silengo S J, Arguello J, Moldovan IR, Tary-Lehmann M Powell TD, Livengood JA, Kinney R M, Huang CYH and Stinchcomb D T, Efficacy of a Tetravalent Chimeric Dengue Vaccine (DENVax) in Cynomolgus Macaques. Am. J. Trop. Med. Hyg., 2011 84(6), 2011, pp. 978–987.
  • Kuerten S, Gruppe TL, Laurentius LM, Kirch C, Tary-Lehmann M, Lehmann PV, Addicks K., Differential patterns of spinal cord pathology induced by MP4, MOG peptide 35-55, and PLP peptide 178-191 in C57BL/6 mice. APMIS. 2011 Jun;119(6):336-46. doi: 10.1111/j.1600-0463.2011.02744.x. Epub 2011 Apr 12.
  • Anthony D, K. Milkovich, W. Zhang, B. Rodriguez, N. Yonkers, M. Tary-Lehmann, P. Lehmann. Dissecting the T cell response: proliferation assays vs. cytokine signatures by ELISPOT Cells 2012, May 1(2), 127-140
  • Frey SE, Winokur PL, Salata RA, El-Kamary SS, Turley CB, Walter EB Jr, Hay CM, Newman FK, Hill HR, Zhang Y, Chaplin P, Tary-Lehmann M, Belshe RB. Safety and immunogenicity of IMVAMUNE® smallpox vaccine using different strategies for a post event scenario. Vaccine 2013 Jun 24;31(29):3025-33.
  • Frey SE, Stapleton JT, Ballas ZK, Rasmussen WL, Kaufman TM, Blevins T, Jensen TL, D Davies H, Tary-Lehmann M, Chaplin P. Human antibody responses following vaccinia immunization using protein microarrays and correlation with cell-mediated and antibody dependent cellular cytotoxicity responses The Journal of Infectious Diseases, jiab111, https://doi.org/10.1093/infdis/jiab111 2021 March;01.